There is new hope for persons struggling with heart failure after the FDA approved Novartis Entresto. This therapy breaks the record for becoming the first to receive approval as a form of treatment for persons struggling with heart failure. The medication will targets persons struggling with both the preserved ejection fraction (HFpEF)(1-3) and reduced ejection […]
